Mifepristone

米非司酮

Report date: 2025/09/23 15:52:30
NMEFirst In Class

Base Information

Drug NameMifepristone
Drug Alias Namemifepristonum美服培酮mifepristonaCorluxinMifegyne +[18] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionProgesterone receptor antagonists
TargetsProgesterone receptor
Therapy Area/IndicationsContraceptionTerminate pregnancyVaginal Bleeding +[32] 
Global Approved IndicationsTerminate pregnancy
Approved Indications in ChinaTerminate pregnancy
Original Approved Country/TerritoryFrance
Original Approved Date1987/01/01
Country/TerritoryFormer Serbia and MontenegroBulgariaUnited States +[12] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesDanco Lab
China Registration ClassN/A

Develop Information

Active CompaniesDanco LabDanco Labs LlcLeiden University Medical Center +[10] 
Inactive CompaniesBiopro Medical LtdDana-Farber Cancer InstituteOptime Care Inc +[20] 
Active IndicationsContraceptionTerminate pregnancyStress Disorders, Post-Traumatic +[8] 
Inactive IndicationsVaginal BleedingPsychotic DisordersAffective Disorders, Psychotic +[24] 

Other Information

ATC CodeG03XB01
Related LinksWikipediaDrugBankKEGG